Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.65%249.72M | 18.08%236.23M | 12.94%856.76M | 18.24%228.68M | 14.90%217.05M | 18.67%217.8M | 3.77%200.06M | 4.54%758.62M | 5.50%193.39M | 0.74%188.91M |
| Cost of revenue | 10.63%200.85M | 18.28%187.44M | 8.23%699.88M | 26.02%196.34M | 1.24%175.37M | 14.99%181.55M | -4.39%158.47M | 7.35%646.67M | 7.00%155.8M | 9.55%173.22M |
| Gross profit | 34.80%48.86M | 17.33%48.8M | 40.13%156.88M | -13.98%32.34M | 100.26%62.68M | 41.37%36.25M | 53.83%41.59M | -9.21%111.95M | -0.28%37.6M | 6.42%31.3M |
| Operating expense | 5.75%21.39M | 23.17%17.37M | 253.61%42.71M | -187.50%-14.47M | 129.34%19.23M | 261.27%20.22M | 38.45%14.1M | -195.08%-27.81M | 246.25%16.54M | -574.93%-65.55M |
| Selling and administrative expenses | ---- | ---- | 8.41%93.13M | ---- | ---- | ---- | ---- | -5.87%85.91M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | 140.45%2.69M | ---- | ---- | ---- | ---- | -65.00%1.12M | ---- | ---- |
| -General and administrative expense | ---- | ---- | 6.66%90.44M | ---- | ---- | ---- | ---- | -3.73%84.79M | ---- | ---- |
| Other operating expenses | 5.75%21.39M | 23.17%17.37M | 488.76%18.69M | ---- | --19.23M | 261.27%20.22M | 38.45%14.1M | -53.90%3.18M | 149.13%16.54M | ---- |
| Total other operating income | ---- | ---- | -40.88%69.11M | -78.44%14.47M | ---- | ---- | ---- | 69.62%116.89M | --67.12M | --65.55M |
| Operating profit | 71.47%27.48M | 14.33%31.43M | -18.31%114.17M | 122.29%46.81M | -55.14%43.44M | -20.05%16.03M | 63.12%27.49M | 48.59%139.76M | -57.03%21.06M | 520.56%96.85M |
| Net non-operating interest income (expenses) | -15.85%-21.89M | -18.18%-21.63M | -16.85%-76.42M | -24.36%-20.48M | -0.95%-19.61M | -16.41%-18.89M | -34.74%-18.3M | -41.61%-65.4M | -20.52%-16.47M | -60.54%-19.42M |
| Non-operating interest income | ---- | ---- | -52.79%144K | ---- | ---- | ---- | ---- | -16.67%305K | ---- | ---- |
| Non-operating interest expense | 15.85%21.89M | 18.18%21.63M | 16.53%76.57M | 24.36%20.48M | 0.95%19.61M | 16.41%18.89M | 34.74%18.3M | 41.16%65.71M | 17.37%16.47M | 60.54%19.42M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -10.46%-1.38M | 68.95%-540K | 38.44%-3.47M | 71.72%-547K | 118.65%72K | 12.87%-1.25M | 7.15%-1.74M | 34.08%-5.63M | 65.84%-1.93M | 62.99%-386K |
| Special income (charges) | 210.32%962K | -797.60%-872K | ||||||||
| Less:Write off | ---- | ---- | -210.32%-962K | ---- | ---- | ---- | ---- | 797.60%872K | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 202.16%4.21M | 24.31%9.26M | -48.06%35.25M | 871.11%25.78M | -95.25%2.92M | -273.29%-4.12M | 433.45%7.45M | 71.96%67.86M | -91.09%2.66M | 2,392.05%61.43M |
| Income tax | 562.88%4.2M | 40.75%5.09M | -183.57%-8.47M | -119.11%-17.38M | -83.79%2.7M | -36.13%633K | 799.75%3.62M | -11.06%10.13M | -273.81%-7.93M | 730.18%16.67M |
| Net income | 100.25%12K | 8.77%4.17M | -24.28%43.71M | 307.72%43.16M | -99.52%216K | -442.86%-4.75M | 285.31%3.83M | 105.66%57.73M | -58.07%10.59M | 9,694.09%44.76M |
| Net income continuous operations | 100.25%12K | 8.77%4.17M | -24.28%43.71M | 307.72%43.16M | -99.52%217K | -442.86%-4.75M | 285.31%3.83M | 105.66%57.73M | -58.07%10.59M | 9,694.09%44.76M |
| Noncontrolling interests | 46.36%483K | -42.22%182K | 133.04%1.07M | 1,918.18%200K | 38.46%72K | 95.27%330K | 27.53%315K | 133.16%457K | 97.22%-11K | -80.23%52K |
| Net income attributable to the company | 90.73%-471K | 13.34%3.98M | -25.53%42.65M | 305.42%42.96M | -99.68%144K | -517.93%-5.08M | 370.55%3.52M | 105.47%57.27M | -58.68%10.6M | 22,945.36%44.71M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 90.73%-471K | 13.34%3.98M | -25.53%42.65M | 305.42%42.96M | -99.68%144K | -517.93%-5.08M | 370.55%3.52M | 105.47%57.27M | -58.68%10.6M | 22,945.36%44.71M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 90.68%-0.0009 | 14.56%0.0076 | -24.28%0.0823 | 305.51%0.0815 | -96.21%0.0033 | -530.44%-0.0097 | 353.45%0.0066 | 105.54%0.1087 | -58.72%0.0201 | 22,207.69%0.087 |
| Diluted earnings per share | 90.68%-0.0009 | 14.56%0.0076 | -24.28%0.0823 | 305.51%0.0815 | -96.21%0.0033 | -530.44%-0.0097 | 353.45%0.0066 | 105.54%0.1087 | -58.72%0.0201 | 22,207.69%0.087 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.